Technology Available for Licensing

Plug-N-Play® Yeast Expression Vectors & Yeast Strains

• For rapid antibody screening in discovery research
• For antibody and recombinant protein production

Recombinant Immunotoxin Development

• ApoLife has developed a class of immunotoxins (IT) capable of targeting oxidative radical production to tumor tissue
• ApoLife is seeking partners for co-development of novel immuntoxins

Research Services

Recombinant Protein, Antibody and Sub-unit Vaccine Expression In

• Yeast
• E. coli
• Mammalian cells

Process Development

• Yeast strain development
• Fermentation Development
• Assay Development- Immuno and cell-based assays

Clone Development for Biogeneric Proteins & Antibodies

Recombinant Antibody Clone Development

• Generation of Fab, scFv from hybridoma and phage library
• Custom Development of Immunotoxins & Fusion Proteins

Strategic Alliances

ApoLife actively pursues strategic alliances with commercial and academic partners interested in cost effective processes for development of recombinant antibodies and proteins. Please contact us for more information about ApoLife’s technology.